Clinical Report: Smoking of illicit drugs may result in serious burns
Overview
A recent study indicates that individuals who smoke drugs like fentanyl and methamphetamine are significantly more likely to suffer severe burns compared to non-users. This finding raises concerns about the safety of smoking as a harm reduction strategy amidst shifting drug use behaviors in the U.S.
Background
The transition from injecting to smoking drugs has been viewed positively by public health experts, as it may reduce the risk of infections and overdose. However, the new research highlights a concerning risk of severe burns associated with smoking drugs, particularly due to the use of powerful butane torches. Understanding these risks is crucial for developing effective harm reduction strategies.
Data Highlights
Population
Percentage of Burns
Smokable drug users
53%
General population
15%
Key Findings
Smokers of drugs like fentanyl and methamphetamine are four times more likely to be treated for burns.
53% of burn cases in Oregon emergency departments involved smokable drug users.
Many burns are linked to the use of butane torches, which can produce intense flames.
Half of the emergency visits for burns are among individuals using smokable drugs.
Overall burn rates did not increase despite the rise in smoking drug use over the study period.
Clinical Implications
Clinicians should be aware of the increased risk of severe burns among patients who smoke drugs and consider advising safer smoking practices. Harm reduction strategies should include education on the dangers of using butane torches and the importance of using safer alternatives.
Conclusion
The study underscores the need for a nuanced understanding of the risks associated with smoking drugs as a harm reduction strategy, particularly concerning severe burn injuries.
